Dana Mullerova | Public Health | Best Researcher Award

Prof. Dr. Dana Mullerova | Public Health | Best Researcher Award

Charles University |Czech Republic

Dr. Dana Müllerová, Ph.D., is a distinguished physician, academic leader and public health expert whose career reflects long-standing contributions to internal medicine, obesity management and preventive healthcare. She holds advanced medical and doctoral degrees from Charles University in Pilsen, where she has built her entire professional path as a clinician at the University Hospital Pilsen and as a dedicated academic shaping medical education and public health policy. Her professional roles include leading the Department of Public Health and Preventive Medicine and contributing to faculty development through senior administrative responsibilities, while her academic appointments highlight progressive recognition of her expertise. Her research focuses on the prevention and treatment of obesity, metabolic disorders, environmental influences on adiposity, nutritional epidemiology and the development of national and European strategies for obesity prevention. She is skilled in clinical obesity management, nutritional assessment, metabolic research methodologies, public health programme development and collaborative policy work. Her influence extends through active roles in European and national associations for the study of obesity, with positions on executive committees and task forces addressing diet, physical activity and public health. She has received recognition through leadership appointments, honorary memberships and her growing scientific impact. Overall, Prof. Müllerová’s career illustrates a sustained commitment to advancing public health, improving obesity care and shaping evidence-based strategies that strengthen population health across clinical, academic and policy domains.

Profile: ORCID

Featured Publications

Sedláček, P., Bludovská, M., Plavinová, I., Zavaďáková, A., Müller, L., & Müllerová, D. (2024). Dietary intake of plant polyphenols: Exploring trend in the Czech population. Central European Journal of Public Health, 32(2), 101–107.

Müllerová, D., Macková, B., & Nejedlá, M. (2024). The obesity epidemic in adults and possible preventive measures in the Czech Republic. Hygiena.

Haluzík, M., Müllerová, D., Sucharda, P., Boženský, J., Holéczy, P., Fried, M., Hainer, V., & Kunešová, M., Málková, I., Slabá, Š., … (2023). Obesity pharmacotherapy – update 2023. Časopis lékařů českých. (PMID: 37185039)

Kladnická, I., Bludovská, M., Plavínová, I., Müller, L., & Müllerová, D. (2022). Obesogens in foods. Biomolecules, 12(5), 680.

Kladnická, I., Čedíková, M., Jedlička, J., Kohoutová, M., Müller, L., Plavínová, I., Kripnerová, M., Bludovská, M., Kunčová, J., & Müllerová, D. (2021). Chronic DDE exposure modifies mitochondrial respiration during differentiation of human adipose-derived mesenchymal stem cells into mature adipocytes. Biomolecules, 11(8), 1068.

Chengfang Tang | Newborn Screening | Best Researcher Award

Mrs. Chengfang Tang | Newborn Screening | Best Researcher Award

Guangzhou Medical University | China

Chengfang Tang, a supervising technician at Guangzhou Newborn Screening Center, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, holds a Master’s degree from Sun Yat-sen University with specialization in instrumental analysis in Pharmaceutical Analysis. With extensive professional experience, she has dedicated her career to clinical and research work on tandem mass spectrometry for newborn screening of multiple genetic metabolic diseases, contributing significantly to early detection and management of rare disorders. She also serves as Secretary of the Genetic Metabolism Group of the Rare Disease Branch of the Guangdong Medical Association, reflecting her leadership in the field. Her research interests center on newborn screening, with notable contributions in advancing diagnostic techniques for genetic metabolic conditions. She has published impactful research in high-quality journals, including International Journal of Neonatal Screening and Clinica Chimica Acta, and has conducted studies on newborn screening for adrenoleukodystrophy. Skilled in advanced laboratory techniques, mass spectrometry applications, and clinical data interpretation, her expertise supports precision medicine and improved child health outcomes. Recognized for her commitment, she has earned professional honors through memberships and leadership roles in scientific associations. Overall, Chengfang Tang’s work exemplifies excellence in research and innovation, strengthening global newborn screening efforts and improving pediatric healthcare.

Profile: ORCID

Featured Publications